Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, Dominic M., Klyubin, Igor, Fadeeva, Julia V., Cullen, William K., Anwyl, Roger, Wolfe, Michael S., Rowan, Michael J., Selkoe, Dennis J.·2002·Nature
DOI 10.1038/416535a

Cited by (1,067)

Items 701–800 of 1,067

  1. Altered aggregation properties of mutant γ‐crystallins cause inherited cataract
    A. Sandilands, A. Hutcheson, H. Long, A. Prescott, G. Vrensen, J. Löster, N. Klopp, R. B. Lutz, J. Graw, S. Masaki et al. · 2002 · The EMBO Journal
  2. Reelin signaling antagonizes β-amyloid at the synapse
    Durakoglugil, Murat S., Chen, Ying, White, Charles L., Kavalali, Ege T., Herz, Joachim · 2009 · Proceedings of the National Academy of Sciences
  3. Modification of nanostructured materials for biomedical applications
    Tao Xu, Ning Zhang, Heather L. Nichols, Donglu Shi, Xuejun Wen · 2006 · Materials Science and Engineering C
  4. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease
    Joannee Zumkehr, Carlos J. Rodríguez‐Ortiz, David Cheng, Zanett Kieu, Thin Wai, Charlesice Hawkins, Jason Kilian, Sharon Lim, Rodrigo Medeiros, Masashi Kitazawa · 2015 · Neurobiology of Aging
  5. Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1
    Jo V. Rushworth, Heledd Jarosz-Griffiths, Nicole T. Watt, Nigel M. Hooper · 2013 · Journal of Biological Chemistry
  6. Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
    Pavlos Alifragis, Jade Marsh · 2018 · Neural Regeneration Research
  7. GluT4: A central player in hippocampal memory and brain insulin resistance
    Ewan C. McNay, Jiah Pearson-Leary · 2019 · Experimental Neurology
  8. Transmembrane Structures for Alzheimer’s Aβ 1−42 Oligomers
    Birgit Strodel, Jason W. L. Lee, Chris S. Whittleston, David J. Wales · 2010 · Journal of the American Chemical Society
  9. Vitamin A and Alzheimer's disease
    Kenjiro Ono, Masahito Yamada · 2011 · Geriatrics and gerontology international/Geriatrics & gerontology international
  10. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
    Zhao, Ruohe, Hu, Wanling, Tsai, Julia, Li, Wei, Gan, Wen-Biao · 2017 · Molecular Neurodegeneration
  11. Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation
    Janelle D. Green, Claire S. Goldsbury, Joerg Kistler, Garth J. S. Cooper, Ueli Aebi · 2004 · Journal of Biological Chemistry
  12. Amyloid β Prevents Activation of Calcium/Calmodulin-Dependent Protein Kinase II and AMPA Receptor Phosphorylation During Hippocampal Long-Term Potentiation
    Danyun Zhao, Joseph B. Watson, Cui-Wei Xie · 2004 · Journal of Neurophysiology
  13. Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?
    Tetsuya Takahashi, Shinichi Katada, Osamu Onodera · 2010 · Journal of Molecular Cell Biology
  14. Alzheimer’s disease: How metal ions define β-amyloid function
    Kasper P. Kepp · 2017 · Coordination Chemistry Reviews
  15. Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
    Dag Sehlin, Hillevi Englund, Barbro Simu, Mikael Karlsson, Martin Ingelsson, Fredrik K. Nikolajeff, Lars Lannfelt, Frida Ekholm Pettersson · 2012 · PLoS ONE
  16. APP Homodimers Transduce an Amyloid-β-Mediated Increase in Release Probability at Excitatory Synapses
    Fogel, Hilla, Frere, Samuel, Segev, Oshik, Bharill, Shashank, Shapira, Ilana, Gazit, Neta, O’Malley, Tiernan, Slomowitz, Edden, Berdichevsky, Yevgeny, Walsh, Dominic M. et al. · 2014 · Cell Reports
  17. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer’s disease
    Álvaro O. Ardiles, Cheril Tapia‐Rojas, Madhuchhanda Mandal, Frédéric Alexandre, Alfredo Kirkwood, Nibaldo C. Inestrosa, Adrián G. Palacios · 2012 · Proceedings of the National Academy of Sciences
  18. Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
    Hideyuki Takeuchi, Hiroyuki Mizoguchi, Yukiko Doi, Shijie Jin, Mariko Noda, Jianfeng Liang, Hua Li, Yan Zhou, Rarami Mori, Satoko Yasuoka et al. · 2011 · PLoS ONE
  19. PTEN recruitment controls synaptic and cognitive function in Alzheimer's models
    Shira Knafo, Cristina Sánchez‐Puelles, Ernest Palomer, Igotz Delgado, Jonathan E. Draffin, Janire Mingo, Tina Wahle, Kanwardeep S. Kaleka, Liping Mou, Inmaculada Pereda-Pérez et al. · 2016 · Nature Neuroscience
  20. Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease
    Nicolau Beckmann, Alexandra Schuler, Thomas Mueggler, Eric P. Meyer, Karl‐Heinz Wiederhold, Matthias Staufenbiel, Thomas Krucker · 2003 · Journal of Neuroscience
  21. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease
    Jack T. Rogers, Ashley Ian Bush, Hyan-Hee Cho, Deborah H. Smith, Andrew M. Thomson, Avi L. Friedlich, Debomoy K. Lahiri, Peter J. Leedman, Xudong Huang, Catherine M. Cahill · 2008 · Biochemical Society Transactions
  22. Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?
    Xinyi Li, Eliezer Masliah, Natàlia Reixach, Joel N. Buxbaum · 2011 · Journal of Neuroscience
  23. Direct Observation of Oligomeric Species formed in the Early Stages of Amyloid Fibril Formation using Electrospray Ionisation Mass Spectrometry
    Andrew M. Smith, Thomas Robert Jahn, Alison E. Ashcroft, Sheena E. Radford · 2006 · Journal of Molecular Biology
  24. Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model
    Francesca Cacucci, Ming Yi, Thomas Joseph Wills, Paul F. Chapman, John M. O'Keefe · 2008 · Proceedings of the National Academy of Sciences
  25. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
    Mai Yamakawa, Daisuke Ito, Takao Honda, Ken‐ichiro Kubo, Mariko Noda, Kazunori Nakajima, Norihiro Suzuki · 2014 · Human Molecular Genetics
  26. From Alzheimer to Huntington: why is a structural understanding so difficult?
    Piero Andrea Temussi, Laura Masino, Annalisa Pastore · 2003 · The EMBO Journal
  27. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
    Cristóvão, Joana S., Santos, Renata, Gomes, Cláudio M. · 2016 · Oxidative Medicine and Cellular Longevity
  28. Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit
    Luisa Diomede, Stefania Rigacci, Margherita Romeo, Massimo Stefani, Mario Salmona · 2013 · PLoS ONE
  29. Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings
    Marcello D’Amelio, Paolo Maria Rossini · 2012 · Progress in Neurobiology
  30. Why Pleiotropic Interventions are Needed for Alzheimer's Disease
    Sally Ann Frautschy, Greg M. Cole · 2010 · Molecular Neurobiology
  31. Alzheimer's disease amyloid β-protein and synaptic function
    Ondrejcak, Tomas, Klyubin, Igor, Hu, Neng-Wei, Barry, Andrew E., Cullen, William K., Rowan, Michael J. · 2010 · NeuroMolecular Medicine
  32. Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
    Fiona Kerr, Oyinkan Sofola-Adesakin, Dobril K. Ivanov, Jemma Gatliff, Beatriz Gomez Perez‐Nievas, Hélène Charlotte Bertrand, Pedro Martinez, Rebecca Callard, Inge Snoeren, Helena M. Cochemé et al. · 2017 · PLoS Genetics
  33. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
    Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, Kuan Hui Chang, Hui Yen Ah, Phui Qi Ng, Hui San Ho, Hsiao Wai Keh, Mayuren Candasamy · 2019 · Biomedicine & Pharmacotherapy
  34. Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade
    J. Steven Jacobsen, Thomas A. Comery, Robert L. Martone, Hassan M. Elokdah, David L. Crandall, Aram Oganesian, Suzan Aschmies, Yolanda M. Kirksey, Cathleen Gonzales, Jane Xu et al. · 2008 · Proceedings of the National Academy of Sciences
  35. Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid β-Protein Assembly and Toxicity
    Kenjiro Ono, Margaret M. Condron, David B. Teplow · 2010 · Journal of Biological Chemistry
  36. Cognitive‐Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies
    Anat Frydman‐Marom, Meirav Rechter, Irit Shefler, Yaron Bram, Deborah E. Shalev, Ehud Gazit · 2008 · Angewandte Chemie International Edition
  37. Electrochemical Detection of Amyloid-β Oligomers Based on the Signal Amplification of a Network of Silver Nanoparticles
    Ning Xia, Xin Wang, Binbin Zhou, Yangyang Wu, Wenhui Mao, Lin Liu · 2016 · ACS Applied Materials & Interfaces
  38. Molecular Distinction between Pathogenic and Infectious Properties of the Prion Protein
    Roberto Chiesa, Pedro Piccardo, Elena Quaglio, Bettina Drisaldi, San Ling Si-Hoe, Masaki Takao, Bernardino Francesco Ghetti, David A. Harris · 2003 · Journal of Virology
  39. Various Dendritic Abnormalities Are Associated with Fibrillar Amyloid Deposits in Alzheimer's Disease
    Jaime Grutzendler, Kathryn A. Helmin, Julia Tsai, Wen‐Biao Gan · 2007 · Annals of the New York Academy of Sciences
  40. Interaction of Tau Protein with Model Lipid Membranes Induces Tau Structural Compaction and Membrane Disruption
    Emmalee M. Jones, Manish Kant Dubey, Phillip J Camp, Briana C. Vernon, Jacek Biernat, Eckhard Mandelkow�, Jaroslaw P. Majewski, Eva Y. Chi · 2012 · Biochemistry
  41. Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
    Christopher M. Henstridge, Makis Tzioras, Rosa Chiara Paolicelli · 2019 · Frontiers in Cellular Neuroscience
  42. Oxidative Metabolites Accelerate Alzheimer's Amyloidogenesis by a Two-Step Mechanism, Eliminating the Requirement for Nucleation
    Jan Bieschke, Qinghai Zhang, Evan T. Powers, Richard Alan Lerner, Jeffery W. Kelly · 2005 · Biochemistry
  43. Exercise Is More Effective than Diet Control in Preventing High Fat Diet-induced β-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice
    Maesako, Masato, Uemura, Kengo, Kubota, Masakazu, Kuzuya, Akira, Sasaki, Kazuki, Hayashida, Naoko, Asada-Utsugi, Megumi, Watanabe, Kiwamu, Uemura, Maiko, Kihara, Takeshi et al. · 2012 · Journal of Biological Chemistry
  44. Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
    Abhay P. Sagare, Robert D. Bell, Berislav V. Zloković · 2012 · Journal of Alzheimer s Disease
  45. Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
    William L. Klein · 2012 · Journal of Alzheimer s Disease
  46. Mechanisms of Transthyretin Inhibition of β-Amyloid AggregationIn Vitro
    Xinyi Li, Xin Zhang, Ali Reza A. Ladiwala, Deguo Du, Jay Kant Yadav, Peter M. Tessier, Peter E. Wright, Jeffery W. Kelly, Joel N. Buxbaum · 2013 · Journal of Neuroscience
  47. Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium
    Adrian M. Isaacs, David B. Senn, Menglan Yuan, James P. Shine, Bruce A. Yankner · 2006 · Journal of Biological Chemistry
  48. Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
    Mikko Hölttä, Oskar Hansson, Ulf Andréasson, Joakim Hertze, Lennart Minthon, Katarina Nägga, Niels Andreasen, Henrik Zetterberg, Kaj Blennow · 2013 · PLoS ONE
  49. Protein Microgels from Amyloid Fibril Networks
    Ulyana Shimanovich, Igor Efimov, Thomas G. Mason, Patrick Flagmeier, Alexander Kai Buell, Aharon Gedanken, Sara Snogerup Linse, Karin S. Åkerfeldt, Christopher Martin Dobson, David A. Weitz et al. · 2014 · ACS Nano
  50. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity
    Ashok N. Hegde · 2004 · Progress in Neurobiology
  51. Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity
    Koon‐Ho Chan, Karen S.L. Lam, On-Yin Cheng, Jason Kwan, Philip Wing‐Lok Ho, Kenneth K.Y. Cheng, Sookja Kim Chung, Jessica Wing-Man Ho, Vivian Yawei Guo, Almin Xu · 2012 · PLoS ONE
  52. Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
    Christopher H. van Dyck, Haakon B. Nygaard, Kewei Chen, Michael Donohue, Rema Raman, Robert A. Rissman, James B. Brewer, Robert A. Koeppe, Tiffany W. Chow, Michael S. Rafii et al. · 2019 · JAMA Neurology
  53. Self Assembly of Short Aromatic Peptides into Amyloid Fibrils and Related Nanostructures
    Ehud Gazit · 2007 · Prion
  54. New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease.
    H. Lashuel, D. Hartley, David Balakhaneh, A. Aggarwal, S. Teichberg, D. J. Callaway · 2002 · Journal of Biological Chemistry
  55. α-Helix targeting reduces amyloid-β peptide toxicity
    Charlotte Nerelius, Anna Sandegren, Hasmik Sargsyan, R. Raunak, Hans Leijonmarck, Urmimala Chatterjee, André Fisahn, Sara Imarisio, David A. Lomas, Damian C. Crowther et al. · 2009 · Proceedings of the National Academy of Sciences
  56. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice
    Huili Liu, Gang Zhao, He Zhang, Shi Li-de · 2013 · Behavioural Brain Research
  57. Protein folding and misfolding: a paradigm of self–assembly and regulation in complex biological systems
    Michele Vendruscolo, Jesús Zurdo, Cait E. MacPhee, Christopher Martin Dobson · 2003 · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
  58. Prion recognition elements govern nucleation, strain specificity and species barriers
    Peter M. Tessier, Susan Lee Lindquist · 2007 · Nature
  59. Chaperone signalling complexes in Alzheimer's disease
    John Koren, Umesh K. Jinwal, Daniel C. Lee, Jeffrey R. Jones, Cody L. Shults, Amelia G. Johnson, Laura J. Anderson, Chad A. Dickey · 2008 · Journal of Cellular and Molecular Medicine
  60. New structures help the modeling of toxic amyloidß ion channels
    Hyunbum Jang, Jie Zheng, Ratnesh Lal, Ruth Nussinov · 2008 · Trends in Biochemical Sciences
  61. Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid
    Volker Nimmrich, Ulrich Ebert · 2009 · Reviews in the Neurosciences
  62. Aβ Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
    Nicholas H. Varvel, Kiran Bhaskar, Anita R. Patil, Sanjay W. Pimplikar, Karl Herrup, Bruce T. Lamb · 2008 · Journal of Neuroscience
  63. Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
    Suzhen Dong, Yale Duan, Yinghe Hu, Zheng Zhao · 2012 · Translational Neurodegeneration
  64. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment
    Hua Zhang, Suya Sun, Lili Wu, Ekaterina I. Pchitskaya, Olga A. Zakharova, Klementina Fon Tacer, Безпрозванный Илья Борисович · 2016 · Journal of Neuroscience
  65. DNAJ Proteins in neurodegeneration: essential and protective factors
    Christina Zarouchlioti, David A. Parfitt, Wenwen Li, Lauren M. Gittings, Michael E. Cheetham · 2017 · Philosophical Transactions of the Royal Society B Biological Sciences
  66. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases
    Lucia Migliore, I. Fontana, Renato Colognato, Fabio Coppedè, Gabriele Siciliano, Luigi Murri · 2004 · Neurobiology of Aging
  67. Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins
    Chihiro Tohda, Noriaki Matsumoto, Kun Zou, Meselhy R. Meselhy, Katsuko Komatsu · 2003 · Neuropsychopharmacology
  68. Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
    2008 · Handbook of Clinical Neurology
  69. Glial cell dysregulation: a new perspective on Alzheimer disease
    Rommy von Bernhardi M. · 2007 · Neurotoxicity Research
  70. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment
    Valeriy G. Ostapchenko, Megan Chen, Mónica S. Guzmán, Yu‐Feng Xie, Natalie E. Lavine, Jue Fan, Flávio H. Beraldo, Amanda C. Martyn, Jillian C. Belrose, Yasuo Mori et al. · 2015 · Journal of Neuroscience
  71. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson?s disease
    Vincenzo Bonifati, Ben A. Oostra, Peter Heutink · 2004 · Journal of Molecular Medicine
  72. Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase
    Hani Atamna, Raj Kumar · 2010 · Journal of Alzheimer s Disease
  73. Cytotoxicity of Intracellular Aβ 42 Amyloid Oligomers Involves Ca 2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate
    Angelo Demuro, Ian Parker · 2013 · Journal of Neuroscience
  74. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models
    Kostylev, Mikhail A., Kaufman, Adam C., Nygaard, Haakon B., Patel, Pujan, Haas, Laura T., Gunther, Erik C., Vortmeyer, Alexander, Strittmatter, Stephen M. · 2015 · Journal of Biological Chemistry
  75. Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
    Koike, Maya A., Green, Kim N., Blurton-Jones, Mathew, LaFerla, Frank M. · 2010 · The American Journal of Pathology
  76. NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus
    Ghiam Yamin · 2009 · Journal of Neuroscience Research
  77. Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca 2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF
    Andrea Cristina Paula-Lima, Tatiana Adasme, Carol D. SanMartín, Adriano Silva Sebollela, Claudio A. Hetz, M. Angélica Carrasco, Sergio Teixeira Ferreira, Cecilia Hidalgo · 2010 · Antioxidants and Redox Signaling
  78. Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals
    Ian F. Smith, Kim N. Green, Frank M. LaFerla · 2005 · Cell Calcium
  79. Structure and function of amyloid in Alzheimer's disease
    Carlos Morgan, Marcela Colombres, Marco Tulio Núñez, Nibaldo C. Inestrosa · 2004 · Progress in Neurobiology
  80. Microglia Activated with the Toll-Like Receptor 9 Ligand CpG Attenuate Oligomeric Amyloid β Neurotoxicity in in Vitro and in Vivo Models of Alzheimer’s Disease
    Doi, Yukiko, Mizuno, Tetsuya, Maki, Yuki, Jin, Shijie, Mizoguchi, Hiroyuki, Ikeyama, Masayoshi, Doi, Minoru, Michikawa, Makoto, Takeuchi, Hideyuki, Suzumura, Akio · 2009 · The American Journal of Pathology
  81. Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
    Boche, Delphine, Denham, Nathan, Holmes, Clive, Nicoll, James A. R. · 2010 · Acta Neuropathologica
  82. Hsp90 Chaperone Inhibitor 17-AAG Attenuates Aβ-Induced Synaptic Toxicity and Memory Impairment
    Yaomin Chen, Bin Wang, Dan Liu, Jing Jing Li, Yue-Qiang Xue, Kazuko Sakata, Ling‐Qiang Zhu, Scott A. Heldt, Huaxi Xu, Francesca‐Fang Liao · 2014 · Journal of Neuroscience
  83. Metal exposure and Alzheimer’s pathogenesis
    Guijian Liu, Weidong Huang, Robert D. Moir, Charles R. Vanderburg, Barry Chi Hong Lai, Zicheng Peng, Rudolph E. Tanzi, Jack T. Rogers, Xudong Huang · 2006 · Journal of Structural Biology
  84. The Experimental Alzheimer’s Disease Drug Posiphen [(+)-Phenserine] Lowers Amyloid-β Peptide Levels in Cell Culture and Mice
    Debomoy K. Lahiri, De‐Mao Chen, Bryan Maloney, Harold W. Holloway, Qian-sheng Yu, Tada Utsuki, Tony Giordano, Kumar Sambamurti, Nigel H. Greig · 2006 · Journal of Pharmacology and Experimental Therapeutics
  85. Site-Specific Blockade of RAGE-V<sub>d</sub>Prevents Amyloid-β Oligomer Neurotoxicity
    Sturchler, Emmanuel, Galichet, Arnaud, Weibel, Mirjam, Leclerc, Estelle, Heizmann, Claus W. · 2008 · The Journal of Neuroscience
  86. Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
    Pitt, Jason, Roth, William, Lacor, Pascale, Smith, Amos B., Blankenship, Matthew, Velasco, Pauline, De Felice, Fernanda, Breslin, Paul, Klein, William L. · 2009 · Toxicology and Applied Pharmacology
  87. β‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor
    Qinwen Wang, Jinqun Wu, Michael J. Rowan, Roger Anwyl · 2005 · European Journal of Neuroscience
  88. A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress–mediated mitochondrial injury
    Pradoldej M Sompol, Wanida Ittarat, Jitbanjong Tangpong, Yumin Chen, I E Doubinskaia, I. Batinic-Haberle, Hafiz Mohmmad Abdul, David Allan Butterfield, Daret K. St. Clair · 2008 · Neuroscience
  89. Atomic Force Microscopy and MD Simulations Reveal Pore-Like Structures of All- d -Enantiomer of Alzheimer’s β-Amyloid Peptide: Relevance to the Ion Channel Mechanism of AD Pathology
    Laura S. Connelly, Hyunbum Jang, Fernando Terán Arce, Ricardo F. Capone, Samuel A. Kotler, Srinivasan Ramachandran, Bruce L. Kagan, Ruth Nussinov, Ratnesh Lal · 2012 · The Journal of Physical Chemistry B
  90. Extending the PRIME model for protein aggregation to all 20 amino acids
    Mookyung Cheon, Iksoo Chang, Carol K. Hall · 2010 · Proteins Structure Function and Bioinformatics
  91. Cholesterol in Alzheimers Disease: Unresolved Questions
    Massimo Stefani, Gianfranco Liguri · 2009 · Current Alzheimer Research
  92. Alzheimer Precursor Protein Interaction with the Nogo-66 Receptor Reduces Amyloid-β Plaque Deposition
    James Hugh Park, David A. Gimbel, Tadzia GrandPré, Jung-Kil Lee, Ji‐Eun Kim, Weiwei Li, Daniel H. S. Lee, Stephen M. Strittmatter · 2006 · Journal of Neuroscience
  93. Oligomerization of Amyloid Aβ16–22 Peptides Using Hydrogen Bonds and Hydrophobicity Forces
    Giorgio Favrin, Anders Irbäck, Sandipan Mohanty · 2004 · Biophysical Journal
  94. The Molecular Basis of Functional Bacterial Amyloid Polymerization and Nucleation
    Xuan Wang, Neal D. Hammer, Matthew R. Chapman · 2008 · Journal of Biological Chemistry
  95. Amyloid accomplices and enforcers
    Andrei T. Alexandrescu · 2004 · Protein Science
  96. Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease
    Hashimoto, Shoko, Saido, Takaomi C. · 2018 · Open Biology
  97. β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade
    Zhang, Fang, Gannon, Mary, Chen, Yunjia, Yan, Shun, Zhang, Sixue, Feng, Wendy, Tao, Jiahui, Sha, Bingdong, Liu, Zhenghui, Saito, Takashi et al. · 2020 · Science Translational Medicine
  98. Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
    Contestabile, Andrea, Benfenati, Fabio, Gasparini, Laura · 2010 · Progress in Neurobiology
  99. Spines, plasticity, and cognition in Alzheimer's model mice
    Spires-Jones, Tara, Knafo, Shira · 2012 · Neural Plasticity
  100. Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane
    Hyunbum Jang, Laura S. Connelly, Fernando Terán Arce, Srinivasan Ramachandran, Bruce L. Kagan, Ratnesh Lal, Ruth Nussinov · 2012 · Journal of Chemical Theory and Computation